Integrating Formulation Development and Manufacturing
News Jul 16, 2009
Symyx Technologies Inc. has announced that the latest edition of its technical e-newsletter - Symyx News is now available for free download from www.symyxnews.com.
The June/July issue of Symyx News showcases how Symyx's Contract Development and Manufacturing Organisation (CDMO) has helped pharmaceutical and biotech companies move promising drug candidates to clinical trials faster with integrated formulation development, and preclinical and CGMP fill/finish manufacturing.
Symyx Isentris software is used worldwide by life science organizations to eliminate data silos and make in-house and public scientific information easily accessible to researchers.
The latest issue of Symyx News discusses how the new Discovery Team Space add-in to Isentris now enables R&D teams to share information extracted and analyzed by individual researchers in a collaborative environment. Discovery Team Space effectively pushes information to research teams by providing a gateway for team members to disseminate new search strategies, reports, and insights to colleagues.
The issue also reports on how Symyx Technologies, Inc. has recently been awarded a grant by the United States Department of Energy (DOE) to conduct research and development of advanced heat transfer fluids for solar thermal power generation.
Symyx News - the technical e-newsletter from Symyx Technologies, offers a source of information relating to the latest technical and applications advances, news and new product introductions for scientists looking to keep informed of innovations that assist their research and development programs.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Towards Personalized Medicine: One Type of Data is Not EnoughNews
To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE